Virax Biolabs Group shares are trading higher after the company announced that its subsidiary, Virax Biolabs, achieved ISO 13485:2016 and ISO 9001:2015 certification for its quality management system.

Benzinga Newsdesk www.benzinga.com Positive 95.6%

Neg 0% Neu 0% Pos 95.6%

Comments

No comments yet. Be the first!